Teleflex Incorporated Share Price

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 18/05/2024 am IST 5-day change 1st Jan Change
217.6 USD -0.43% Intraday chart for Teleflex Incorporated +6.72% -12.71%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.09B 257B Sales 2025 * 3.26B 271B Capitalization 10.25B 854B
Net income 2024 * 409M 34.05B Net income 2025 * 543M 45.21B EV / Sales 2024 * 3.66 x
Net Debt 2024 * 1.06B 88.65B Net Debt 2025 * 507M 42.19B EV / Sales 2025 * 3.3 x
P/E ratio 2024 *
28.1 x
P/E ratio 2025 *
19.3 x
Employees 14,500
Yield 2024 *
0.63%
Yield 2025 *
0.63%
Free-Float 97.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.43%
1 week+6.72%
Current month+4.26%
1 month+5.36%
3 months-13.32%
6 months+2.28%
Current year-12.71%
More quotes
1 week
208.39
Extreme 208.39
220.27
1 month
197.99
Extreme 197.99
220.27
Current year
197.99
Extreme 197.99
256.85
1 year
177.63
Extreme 177.633
262.97
3 years
177.63
Extreme 177.633
428.36
5 years
177.63
Extreme 177.633
449.38
10 years
101.95
Extreme 101.95
449.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/09/01
Director of Finance/CFO 62 01/11/01
Compliance Officer - 01/18/01
Members of the board TitleAgeSince
Director/Board Member 69 01/18/01
Director/Board Member 64 01/09/01
Director/Board Member 69 01/19/01
More insiders
Date Price Change Volume
17/24/17 217.6 -0.43% 392,913
16/24/16 218.6 -0.56% 1,238,765
15/24/15 219.8 +3.37% 489,886
14/24/14 212.6 +2.56% 470,457
13/24/13 207.3 +1.66% 457,341

Delayed Quote Nyse, May 18, 2024 at 01:30 am IST

More quotes
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
217.6 USD
Average target price
245.2 USD
Spread / Average Target
+12.68%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW